| Literature DB >> 21189846 |
Mohamed E Shams1, Hosam M Atef.
Abstract
BACKGROUND: Postoperative pain control has been studied extensively, including many perioperative pain control procedures. Unfortunately, the impact of the surgical technique was not objectively studied. AIM: The aim of this study is to evaluate if the type of surgical dissection needed for extensive abdominal wall dissection actually has an effect in the reduction of postoperative pain or not.Entities:
Keywords: Postoperative pain; abdominal wall dissection; impact of surgical factor
Year: 2010 PMID: 21189846 PMCID: PMC2980655 DOI: 10.4103/1658-354X.71134
Source DB: PubMed Journal: Saudi J Anaesth
Means±SE of dosage of Nalbufen as an indicator for postoperative pain severity in patients having their ventral hernia repaired using sharp and blunt dissection in both sexes
| Type of surgical dissection | Postoperative follow up time | |||||
|---|---|---|---|---|---|---|
| 3 hours | 6 hours | 12 hours | 24 hours | 48 hours | ||
| Sharp dissection | Male | 1 (±0.65) | 4.5 (±0.50) | 6.5 (±0.73) | 9.5 (±0.73) | 16.5 (±0.91) |
| Female | 0.67 (±0.45) | 4.67 (±0.45) | 6.67 (±1.14) | 10.33 (±1.25) | 16.17 (±1.40) | |
| Overall | 0.8 (±0.37) | 4.6 (±0.33) | 6.6 (±0.73) | 10 (±0.79) | 16.3 (±0.90) | |
| Blunt dissection | Male | 6.18 (±0.63) | 9.45 (±0.81) | 14.91 (±0.95) | 19.27 (±0.49) | 27.64 (±0.85) |
| Female | 5.33 (±0.67) | 8.89 (±1.11) | 14.22 (±0.97) | 17.33 (±0.67) | 26.22 (±1.90) | |
| Overall | 5.8 (±0.46) | 9.2 (±0.66) | 14.6 (±0.67) | 18.4 (±0.45) | 27 (±0.96) | |
Maximum dosage of Nalbufen (mg) as an indicator for postoperative pain severity in patients having their ventral hernia repaired using sharp and blunt dissection in both sexes
| Type of surgical dissection | Postoperative follow up time | |||||
|---|---|---|---|---|---|---|
| 3 hours | 6 hours | 12 hours | 24 hours | 48 hours | ||
| Sharp dissection | Male | 4 | 8 | 8 | 12 | 20 |
| Female | 4 | 8 | 16 | 20 | 26 | |
| Overall | 4 | 8 | 16 | 20 | 26 | |
| Blunt dissection | Male | 8 | 12 | 20 | 20 | 32 |
| Female | 8 | 16 | 20 | 20 | 36 | |
| Overall | 8 | 16 | 20 | 20 | 36 | |
Coefficient of variability of dosage of Nalbufen as an indicator for postoperative pain severity in patients having their ventral hernia repaired using sharp and blunt dissection in both sexes
| Type of surgical dissection | Postoperative follow up time | |||||
|---|---|---|---|---|---|---|
| 3 hours | 6 hours | 12 hours | 24 hours | 48 hours | ||
| Sharp dissection | Male | 185.16 | 31.43 | 31.85 | 21.79 | 15.54 |
| Female | 233.55 | 33.36 | 59.08 | 41.95 | 30.05 | |
| Overall | 205.20 | 31.86 | 49.26 | 35.54 | 24.63 | |
| Blunt dissection | Male | 33.79 | 28.52 | 21.09 | 8.40 | 10.14 |
| Female | 37.50 | 37.50 | 20.3 | 11.54 | 21.72 | |
| Overall | 35.20 | 31.86 | 20.42 | 10.93 | 15.85 | |
Mean squares of least square analysis of variance of factors affecting the amount of Nalbufen needed for control of postoperative pain in patients having their ventral hernia repaired using sharp and blunt dissection in both sexes
| Source of variability | Degree of freedom | Postoperative follow up time | ||||
|---|---|---|---|---|---|---|
| 3 hours | 6 hours | 12 hours | 24 hours | 48 hours | ||
| Type of dissection | 1 | 236.36 | 205.22 | 621.098 | 685.56 | 1094.41 |
| Gender | 1 | 3.403 | 0.388 | 0.659 | 2.981 | 7.441 |
| Operative dissection | 1 | 0.647 | 1.307 | 1.775 | 18.735 | 2.847 |
| Error | 36 | 36 | 36 | 36 | 36 | 36 |
| R-squared | 0.668 | 0.513 | 0.636 | 0.712 | 0.642 | |
Statistically significant P≤0.005
Highly statistically significant P≤0.0005
Minimum of dosage of Nalbufen as an indicator for postoperative pain severity in patients having their ventral hernia repaired using sharp and blunt dissection in both sexes
| Type of surgical dissection | Postoperative follow up time | |||||
|---|---|---|---|---|---|---|
| 3 hours | 6 hours | 12 hours | 24 hours | 48 hours | ||
| Sharp dissection | Male | 0 | 4 | 4 | 8 | 12 |
| Female | 0 | 4 | 4 | 4 | 8 | |
| Overall | 0 | 4 | 4 | 4 | 8 | |
| Blunt dissection | Male | 4 | 4 | 8 | 16 | 24 |
| Female | 4 | 4 | 12 | 16 | 20 | |
| Overall | 4 | 4 | 8 | 16 | 20 | |